Research
New synthetic methods for biologically active/druglike molecules. Design and synthesis of integrin antagonists. Total synthesis.
The integrins are a family of transmembrane receptors which mediate cell-cell and cell-ECM adhesion, and signalling across the cell membrane involved in pathways controlling cell migration, proliferation, differentiation, cell survival and apoptosis. In cancers, their vital role in the cross-talk between the cell and extracellular matrix enhances the growth, migration, invasion and metastasis of cancer cells. The RGD-binding subfamily of integrins are of particular interest as anticancer targets, since there is strong evidence that their expression in cancers is correlated with tumour progression, treatment resistance, and a cancer stem cell phenotype. Research areas currently under investigation include:
- Investigation of combination therapies to
combat integrin-mediated resistance to existing anticancer agents
- Targeted integrin degradation
- Synthesis and characterisation of new integrin
targeting small molecules for the treatment of advanced cancers, particularly
metastatic prostate cancer and malignant melanoma.
- Synthesis of biologically active natural products, and derivatives. Current targets include Nigramide Q and Scopariusicides A-C.
Postgraduate Supervision
Currently Dr Sheldrake is supervisor to the following postgraduate students:
Name: Reuben
McKay
Contact
details: r.c.mckay@bradford.ac.uk
Project
outline: Reuben’s current research uses enamine cyclisation reactions to
explore analogues of natural products with potential antibacterial and
anticancer activities.
Note list only includes students who have opted in.
Supervision Capacity and Current Project Availability
I currently have capacity to supervise new Self-funded Postgraduate Researchers. To see available projects, please visit https://www.findaphd.com/phds/faculty-of-life-sciences/?c0g71Ug0 To apply online, complete our application form Complete
Postgraduate Enquiry Form HERE